144 related articles for article (PubMed ID: 36464180)
1. The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2 N1 nasopharyngeal carcinoma: A multicenter retrospective study.
Hu YJ; Lu TZ; Guo QJ; Zhang L; Xiao YP; Lin SJ; Zhou H; Zheng DC; Ding SR; Liu LZ; Gong XC; Li JG; Pan JJ; Xia YF
Radiother Oncol; 2023 Jan; 178():109436. PubMed ID: 36464180
[TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort.
Chin O; Yu E; O'Sullivan B; Su J; Tellier A; Siu L; Waldron J; Kim J; Hansen A; Hope A; Cho J; Giuliani M; Ringash J; Spreafico A; Bratman S; Hosni A; Hahn E; Tong L; Xu W; Huang SH
Radiother Oncol; 2021 Dec; 165():94-102. PubMed ID: 34718052
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of radiologic extranodal extension and its potential role in future N classification for nasopharyngeal carcinoma.
Lu T; Hu Y; Xiao Y; Guo Q; Huang SH; O'Sullivan B; Fang Y; Zong J; Chen Y; Lin S; Chen Y; Pan J
Oral Oncol; 2019 Dec; 99():104438. PubMed ID: 31654937
[TBL] [Abstract][Full Text] [Related]
4. Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems.
Mao Y; Wang S; Lydiatt W; Shah JP; Colevas AD; Lee AWM; O'Sullivan B; Guo R; Luo W; Chen Y; Tian L; Tang L; Sun Y; Liu L; Ren J; Ma J
Radiother Oncol; 2021 Apr; 157():114-121. PubMed ID: 33516790
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
Tsai TY; Chou YC; Lu YA; Kang CJ; Huang SF; Liao CT; Chang KP
Oral Oncol; 2021 Nov; 122():105518. PubMed ID: 34507205
[TBL] [Abstract][Full Text] [Related]
6. Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Billfalk-Kelly A; Yu E; Su J; O'Sullivan B; Waldron J; Ringash J; Bartlett E; Perez-Ordonez B; Weinreb I; Bayley A; Bratman SV; Cho J; Giuliani M; Hope A; Hosni A; Kim J; Hansen AR; de Almeida J; Tong L; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1017-1027. PubMed ID: 30953712
[TBL] [Abstract][Full Text] [Related]
7. Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram.
Ding J; Chen J; Lin Y; Hong J; Huang C; Fei Z; Chen C
Braz J Otorhinolaryngol; 2024; 90(2):101363. PubMed ID: 38101121
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
Huang SH; O'Sullivan B; Su J; Bartlett E; Kim J; Waldron JN; Ringash J; de Almeida JR; Bratman S; Hansen A; Bayley A; Cho J; Giuliani M; Hope A; Hosni A; Spreafico A; Siu L; Chepeha D; Tong L; Xu W; Yu E
Radiother Oncol; 2020 Mar; 144():13-22. PubMed ID: 31710939
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Li PJ; Mo HY; Luo DH; Hu WH; Jin T
Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
[TBL] [Abstract][Full Text] [Related]
10. High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma.
Hu Y; Lu T; Huang SH; Lin S; Chen Y; Fang Y; Zhou H; Chen Y; Zong J; Zhang Y; Chen Y; Pan J; Xiao Y; Guo Q
Head Neck; 2019 Sep; 41(9):3317-3327. PubMed ID: 31206864
[TBL] [Abstract][Full Text] [Related]
11. Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx.
Ai QY; King AD; Poon DMC; Mo FKF; Hui EP; Tong M; Ahuja AT; Ma BBY; Chan ATC
Oral Oncol; 2019 Jan; 88():124-130. PubMed ID: 30616782
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
[TBL] [Abstract][Full Text] [Related]
13. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract][Full Text] [Related]
14. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Tang LL; Guo R; Zhou G; Sun Y; Liu LZ; Lin AH; Mai H; Shao J; Li L; Ma J
PLoS One; 2014; 9(10):e108375. PubMed ID: 25302611
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.
Chen WH; Tang LQ; Guo SS; Chen QY; Zhang L; Liu LT; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
Medicine (Baltimore); 2016 Feb; 95(5):e2642. PubMed ID: 26844482
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
19. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
Liao JF; Ma L; Du XJ; Lan M; Guo Y; Zheng L; Xia YF; Luo W
PLoS One; 2016; 11(1):e0146787. PubMed ID: 26824230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
